Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Cardiff Lexington Corporation
- Market Cap
- Unavailable
- Price
- $0.6371
- % Change (Daily % change from the live per-ticker quote feed.)
- +6.19%
- Volume
- 2.2K
About
Headquartered in Fort Lauderdale, Florida, Cardiff Lexington Corporation, which was established in 2001, offers a diverse range of services. The company provides affordable housing solutions and comprehensive tax resolution services across the United States. Its operations include the leasing and sale of mobile homes and mobile home parks, presenting an alternative to conventional housing. Furthermore, Cardiff Lexington assists individuals and businesses with their federal and state tax obligations by offering tax preparation, bookkeeping, and tax resolution services. The firm is also involved in the commercial real estate sector. The company adopted its current name in January 2018, having previously been known as Cardiff International, Inc.
Quick stats
Shares outstanding—
Computed float6.3M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryMedical - Care Facilities
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000811222
AI Summary
AI-generated1/7
majormixedm and a
Cardiff Lexington Corporation Announces Letter of Intent for Proposed Acquisition of Leading Musculoskeletal Healthcare Platform
Cardiff Lexington (OTCQX: CDIX) signed a letter of intent to acquire a multi-location musculoskeletal healthcare platform for up to $104 million, its largest disclosed transaction.
Consideration includes $30 million cash at closing, $10 million in deferred notes, preferred equity giving sellers 35% of fully diluted shares, and up to $12 million of stock earnouts tied to 2027-2029 EBITDA thresholds of $15M/$18M/$22M.
The LOI is non-binding as to closing, and the company has not yet obtained binding financing commitments; projected close is November 16, 2026 after a 45-day exclusivity and diligence period.
For CDIX shareholders, the deal offers scale and an ASC-integration growth path, but meaningful dilution and financing uncertainty are the key risks.
Red flags
- LOI is non-binding; no assurance definitive agreements will be executed
- No binding financing commitments obtained; financing may not be available on acceptable terms or at all
- Sellers receive 35% of fully diluted equity post-closing -- substantial dilution
- Target financial statements not yet audited; PCAOB audit only planned post-closing
- Preferred equity carries 1x preference senior to common stock
- Target financial statements for the six months ended June 30, 2026 will only be reviewed, not audited, post-closing